Takeda Pharmaceutical Company Limited (LON:0A87)
London
· Delayed Price · Currency is GBP · Price in USD 14.42
0.00 (0.00%)
At close: Nov 25, 2025
LON:0A87 Ratios and Metrics
Market cap in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 24, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 33,641 | 34,886 | 34,363 | 41,118 | 33,976 | 40,888 | Upgrade
|
| Market Cap Growth | 0.24% | 1.52% | -16.43% | 21.02% | -16.91% | 6.29% | Upgrade
|
| Enterprise Value | 55,424 | 60,410 | 60,110 | 66,084 | 56,723 | 71,294 | Upgrade
|
| Last Close Price | 10.94 | 11.31 | 10.54 | 12.35 | 10.01 | 12.14 | Upgrade
|
| PE Ratio | 202.33 | 62.54 | 45.57 | 21.33 | 23.57 | 16.57 | Upgrade
|
| PS Ratio | 1.52 | 1.47 | 1.54 | 1.68 | 1.52 | 1.95 | Upgrade
|
| PB Ratio | 0.94 | 0.97 | 0.90 | 1.06 | 0.95 | 1.20 | Upgrade
|
| P/FCF Ratio | 6.58 | 7.88 | 12.14 | 8.08 | 5.42 | 6.92 | Upgrade
|
| P/OCF Ratio | 5.58 | 6.39 | 9.16 | 6.92 | 4.83 | 6.16 | Upgrade
|
| EV/Sales Ratio | 2.60 | 2.55 | 2.69 | 2.70 | 2.54 | 3.40 | Upgrade
|
| EV/EBITDA Ratio | 9.70 | 9.48 | 10.04 | 8.46 | 7.65 | 11.04 | Upgrade
|
| EV/EBIT Ratio | 23.87 | 20.76 | 22.99 | 17.54 | 15.09 | 25.62 | Upgrade
|
| EV/FCF Ratio | 10.83 | 13.65 | 21.23 | 12.99 | 9.06 | 12.07 | Upgrade
|
| Debt / Equity Ratio | 0.73 | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | Upgrade
|
| Debt / EBITDA Ratio | 4.37 | 3.96 | 4.57 | 3.79 | 4.07 | 5.16 | Upgrade
|
| Debt / FCF Ratio | 5.10 | 5.94 | 10.10 | 5.81 | 4.81 | 5.64 | Upgrade
|
| Asset Turnover | 0.30 | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | Upgrade
|
| Inventory Turnover | 1.24 | 1.30 | 1.30 | 1.36 | 1.40 | 1.34 | Upgrade
|
| Quick Ratio | 0.65 | 0.44 | 0.50 | 0.49 | 0.73 | 1.00 | Upgrade
|
| Current Ratio | 1.37 | 1.01 | 1.11 | 0.97 | 1.21 | 1.53 | Upgrade
|
| Return on Equity (ROE) | 0.47% | 1.52% | 2.12% | 5.27% | 4.24% | 7.60% | Upgrade
|
| Return on Assets (ROA) | 2.09% | 2.40% | 2.15% | 2.85% | 2.88% | 2.06% | Upgrade
|
| Return on Capital (ROIC) | 2.44% | 2.84% | 2.61% | 3.57% | 3.62% | 2.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 4.80% | 3.90% | 5.40% | 5.40% | 3.80% | Upgrade
|
| Earnings Yield | 0.49% | 1.60% | 2.20% | 4.69% | 4.24% | 6.04% | Upgrade
|
| FCF Yield | 15.21% | 12.69% | 8.24% | 12.37% | 18.44% | 14.44% | Upgrade
|
| Dividend Yield | 1.56% | 8.96% | 9.33% | 8.86% | 11.27% | 9.73% | Upgrade
|
| Payout Ratio | 935.06% | 280.28% | 199.34% | 88.14% | 123.30% | 75.36% | Upgrade
|
| Buyback Yield / Dilution | -0.65% | -1.58% | -0.67% | 0.46% | -0.23% | -0.47% | Upgrade
|
| Total Shareholder Return | 0.91% | 7.38% | 8.67% | 9.32% | 11.04% | 9.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.